Cambridge Investment Research Advisors, Inc. Corcept Therapeutics Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 12,005 shares of CORT stock, worth $830,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,005
Previous 19,766
39.26%
Holding current value
$830,145
Previous $996,000
37.65%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CORT
# of Institutions
474Shares Held
84.4MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.14 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$690 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$535 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$425 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$268 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.41B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...